GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Accrelist Ltd (SGX:QZG) » Definitions » ROE % Adjusted to Book Value

Accrelist (SGX:QZG) ROE % Adjusted to Book Value : -6.12% (As of Sep. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Accrelist ROE % Adjusted to Book Value?

Accrelist's ROE % for the quarter that ended in Sep. 2024 was -6.73%. Accrelist's PB Ratio for the quarter that ended in Sep. 2024 was 1.10. Accrelist's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -6.12%.


Accrelist ROE % Adjusted to Book Value Historical Data

The historical data trend for Accrelist's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accrelist ROE % Adjusted to Book Value Chart

Accrelist Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -173.20 -5.27 -62.05 -24.17 -13.80

Accrelist Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.50 -38.86 29.27 -52.78 -6.12

Competitive Comparison of Accrelist's ROE % Adjusted to Book Value

For the Medical Care Facilities subindustry, Accrelist's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accrelist's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Accrelist's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Accrelist's ROE % Adjusted to Book Value falls into.


;
;

Accrelist ROE % Adjusted to Book Value Calculation

Accrelist's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-16.15% / 1.17
=-13.80%

Accrelist's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-6.73% / 1.10
=-6.12%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Accrelist ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Accrelist's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Accrelist Business Description

Traded in Other Exchanges
N/A
Address
10 Ubi Crescent, Ubi Techpark, Lobby E No. 03-95, Singapore, SGP, 408564
Accrelist Ltd is focused on the distribution of electronics components, plastic injection molding, mold design, and fabrication services. The company's segment comprises a Mechanical business unit (MBU), Aesthetic Medical Services (AMS), and others. Accrelist is focused on maintaining a diversified customer mix and product portfolio for MBU and EBU while continuing to expand upon the medical aesthetic products and services provided to consumers. it generates a vast majority of revenue from the MBU segment.

Accrelist Headlines

No Headlines